Skip to main content

Our Law Firm Articles

Earlier this week, the current U.S. Attorney General Jefferson Sessions announced that the Department of Justice intends to file a “statement of interest” in filing its own lawsuit against opioid…

Despite demonstrated dangers and side effects, which are the primary cause of action in the dozens of lawsuits currently part of a mass tort action, the atypical antipsychotic medication Abilify…

The organization Human Rights Watch recently

VARUBI® (rolapitant) was originally developed by Schering-Plough, which was…

Of the five largest mass lawsuits either underway or scheduled for trial in 2018, three are about prescription drugs, with a fourth one listing a defective medical device as the cause of action.…

Drugmaker Allergan, which has most recently come under fire over the opioid-based medication Viberzi, has been targeted in numerous lawsuits over the years for many reasons. In the wake of 120 FDA…

The Invokana CANVAS study, mandated by the FDA as part of post-marketing requirements and sponsored by…

Ignoring its own guidelines for the assessment of cancer risks, the EPA has rejected evidence indicating that glyphosate, the…

This week, the FDA announced its approval for a new gene therapy designed to treat a rare genetic disorder that causes blindness. According to the…

Customize This